PTEN-loss in glioblastoma cells fosters CD3+ T cells apoptosis upon cell-cell contact and such effect can be reverted by pre-treatment with PI3K/AKT pathway inhibitors, suggesting a possible therapeutic strategy encompassing PI3K/AKT-targeted inhibitors in combination with immunotherapy [119]. This evidence concerns the gene PTEN and glioblastoma.